Musculoskeletal
Knee Osteoarthritis
4
Pipeline Programs↗
11
Active Trials↗
8
Companies Involved↗
Knee Osteoarthritis is an early-stage landscape with 4 programs across 8 companies. The most active players are Eli Lilly, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Guangdong Hongzhi Health Technology.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical2
Phase 1
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
17
clinical trials
Completed6 · 35%
Not yet recruiting6 · 35%
Recruiting5 · 29%
Clinical Trials
Trial Activity
17 trials
Efficacy of Therapy With Intra-articular Injections of PRP Compared With Therapy With Intra-articular Injections of HA, in Patients With Grade III or IV GONArthrosis: a Prospective Randomized Open-label Study
Recruiting·CCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer·Preclinical·NCT07016672·150 enrolled
A Randomized Controlled Trial of a Health Aids for Knee Osteoarthritis
Not yet recruiting·—·Preclinical·NCT07669532·159 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)